XXXX in the treatment of early diabetic nephropathy
A, objective:
By XXX on early stage of diabetic nephropathy syndrome of yin deficiency with phlegm and blood stasis type two treatment, to observe its efficacy and safety and to explore its possible mechanism of action.
One, method:
80 cases accord with the conditions of the DN Qi and yin deficiency with blood stasis type two patients were randomly divided into control group and treatment group with 40 cases in each group, the control group for diabetes education, to control diet, adequate exercise, to conventional oral hypoglycemic agents or giving insulin hypoglycemic treatment, hypertension, dyslipidemia and be antihypertensive lipid symptomatic therapy; treatment group in the control group based on the use of XXXX, 4 capsules each time, 3 times a day ( by preparation center production ) oral treatment, for one month. Comparative analysis of before and after the treatment with fasting plasma glucose ( FPG ), 2 hour postprandial plasma glucose ( 2hPG ), retinol-binding protein ( RBP ), urine protein and superoxide dismutase ( SOD ), angiotensin converting enzyme ( ACE ) and other indicators.
XXXX early treatment of diabetic nephropathy clinical research
A, purpose:
Through the XXX to early diabetic nephropathy card to belong to qi and Yin and holding clamp type of treatment phlegm and blood stasis, to observe its efficacy and safety and discuss the possible mechanism.
A, method:
80 patients in the conditions with qi and Yin and holding DN clip stasis syndrome patients were randomly divided into the treatment group and control group all 40 cases and control to diabetes education, ask control diet, exercising, to conventional oral medications or give insulin hypoglycemic therapy, have high blood pressure, blood fat unusual person and at the same time be step-down lipid symptomatic treatment; The treatment group based in the control group combined with XXXX, every time 4 grain, every day three times (by preparations center production) oral therapy, a month for one period of treatment. Comparative analysis of fasting plasma glucose before and after treatment (FPG), 2 after a meal